FDA steering on ANDA submissions
With the US Generic Drug Person Price Amendments (GDUFA) reauthorized by Congress on September 30, 2022, referred to as GDUFA III, these provisions are in impact October 1, 2022, by means of September 30, 2027.…
Tag: ANDA